News

May 24, 2023

Gabelli Funds LLC Lowers Position in ICU Medical, Inc. (NASDAQ:ICUI)

Gabelli Funds LLC trimmed its position in ICU Medical, Inc. (NASDAQ:ICUI - Get

Gabelli Funds LLC trimmed its position in ICU Medical, Inc. (NASDAQ:ICUI - Get Rating) by 8.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 72,050 shares of the medical instruments supplier's stock after selling 6,300 shares during the period. Gabelli Funds LLC owned 0.30% of ICU Medical worth $11,346,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in the company. Vanguard Group Inc. grew its position in shares of ICU Medical by 8.8% in the 1st quarter. Vanguard Group Inc. now owns 2,122,104 shares of the medical instruments supplier's stock worth $472,466,000 after buying an additional 171,851 shares during the period. Wellington Management Group LLP increased its stake in shares of ICU Medical by 71.6% during the first quarter. Wellington Management Group LLP now owns 1,516,089 shares of the medical instruments supplier's stock valued at $337,542,000 after purchasing an additional 632,609 shares in the last quarter. JPMorgan Chase & Co. increased its stake in shares of ICU Medical by 1.1% during the fourth quarter. JPMorgan Chase & Co. now owns 754,421 shares of the medical instruments supplier's stock valued at $118,806,000 after purchasing an additional 8,256 shares in the last quarter. Fuller & Thaler Asset Management Inc. lifted its holdings in shares of ICU Medical by 7.8% during the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 578,533 shares of the medical instruments supplier's stock valued at $91,107,000 after purchasing an additional 41,756 shares during the last quarter. Finally, State Street Corp boosted its position in shares of ICU Medical by 2.6% in the 3rd quarter. State Street Corp now owns 572,265 shares of the medical instruments supplier's stock worth $86,183,000 after purchasing an additional 14,316 shares in the last quarter. Institutional investors own 93.88% of the company's stock.

In other news, VP Virginia Ruth Sanzone sold 250 shares of the stock in a transaction on Tuesday, April 11th. The stock was sold at an average price of $175.00, for a total transaction of $43,750.00. Following the transaction, the vice president now directly owns 4,678 shares of the company's stock, valued at approximately $818,650. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. In other ICU Medical news, VP Virginia Ruth Sanzone sold 250 shares of the business's stock in a transaction dated Tuesday, April 11th. The stock was sold at an average price of $175.00, for a total transaction of $43,750.00. Following the completion of the sale, the vice president now directly owns 4,678 shares in the company, valued at approximately $818,650. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Elisha W. Finney sold 194 shares of the stock in a transaction that occurred on Wednesday, June 7th. The stock was sold at an average price of $190.41, for a total transaction of $36,939.54. Following the completion of the transaction, the director now owns 1,481 shares in the company, valued at approximately $281,997.21. The disclosure for this sale can be found here. Insiders sold 902 shares of company stock valued at $158,550 over the last three months. Insiders own 7.50% of the company's stock.

ICUI stock opened at $191.93 on Friday. The stock's 50 day simple moving average is $182.68 and its 200 day simple moving average is $172.59. The company has a current ratio of 2.62, a quick ratio of 1.01 and a debt-to-equity ratio of 0.77. ICU Medical, Inc. has a 12-month low of $128.90 and a 12-month high of $212.43. The stock has a market capitalization of $4.62 billion, a PE ratio of -99.96 and a beta of 0.62.

ICUI has been the subject of a number of recent research reports. 51job reiterated a "maintains" rating on shares of ICU Medical in a research note on Tuesday, May 9th. StockNews.com assumed coverage on ICU Medical in a research report on Thursday, May 18th. They issued a "hold" rating for the company. Finally, KeyCorp increased their price objective on shares of ICU Medical from $200.00 to $216.00 in a research report on Tuesday, May 9th.

ICU Medical, Inc engages in the development, manufacture, and sale of innovative medical devices used in vascular therapy and critical care applications. Its product portfolio includes intravenous smart pumps, sets, connectors, closed transfer devices for hazardous drugs, cardiac monitoring systems, IV solutions, IV smart pumps with pain management and safety software technology, dedicated and non-dedicated IV sets and needle-free connectors.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].

Before you consider ICU Medical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ICU Medical wasn't on the list.

While ICU Medical currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

MarketBeat's analysts have just released their top five short plays for June 2023. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.